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Damage to the sensory hair cells and the spiral ganglion neurons of the cochlea leads to deafness. Induced pluripotent stem cells
(iPSCs) are a promising tool to regenerate the cells in the inner ear that have been aﬀected by pathology or have been lost. To
facilitate the clinical application of iPSCs, the reprogramming process should minimize the risk of introducing undesired genetic
alterations while conferring the cells the capacity to diﬀerentiate into the desired cell type. Currently, reprogramming induced
by synthetic mRNAs is considered to be one of the safest ways of inducing pluripotency, as the transgenes are transiently
delivered into the cells without integrating into the genome. In this study, we explore the ability of integration-free human-
induced pluripotent cell lines that were reprogrammed by mRNAs, to diﬀerentiate into otic progenitors and, subsequently, into
hair cell and neuronal lineages. hiPSC lines were induced to diﬀerentiate by culturing them in the presence of ﬁbroblast growth
factors 3 and 10 (FGF3 and FGF10). Progenitors were identiﬁed by quantitative microscopy, based on the coexpression of otic
markers PAX8, PAX2, FOXG1, and SOX2. Otic epithelial progenitors (OEPs) and otic neuroprogenitors (ONPs) were puriﬁed
and allowed to diﬀerentiate further into hair cell-like cells and neurons. Lineages were characterised by immunocytochemistry
and electrophysiology. Neuronal cells showed inward Na+ (INa) currents and outward (Ik) and inward K
+ (IK1) currents while
hair cell-like cells had inward IK1 and outward delayed rectiﬁer K
+ currents, characteristic of developing hair cells. We conclude
that human-induced pluripotent cell lines that have been reprogrammed using nonintegrating mRNAs are capable to
diﬀerentiate into otic cell types.
1. Introduction
Hearing loss has a huge impact on quality of life, as well as an
economic cost for society. Advances in hearing aid and
cochlea implant technologies oﬀer partial functional recovery
for some, but for many, there is no curative treatment. Gen-
eration of biological therapeutic agents to replace damaged
cellular components of the inner ear remains a goal of regen-
erative medicine, which could eventually lead to treatment
options for excluded patients and better outcomes for those
currently dependent on electronic devices. Key work under-
taken on mouse and human stem cells has made signiﬁcant
advances towards this objective [1–6]. Furthermore, progen-
itors derived from human embryonic stem cells (hESCs)
have been transplanted into the cochleae of deafened gerbils,
eliciting functional recovery [6].
The identiﬁcation of potential sources of “adult stem
cells” within the body (reviewed in [7]) has raised hopes for
autologous, patient-speciﬁc cellular therapies. While this
concept is attractive both from ethical and patient compati-
bility perspectives, to date, adult stem cell populations have
proven diﬃcult to manipulate to raise progenies beyond their
natural potential. These cell types generally show far less dif-
ferentiation plasticity than their embryonic counterparts,
limiting their widespread application. For example, studies
attempting to steer mesenchymal stem cells towards an otic
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fate have provided preliminary proof-of-principle, but diﬀer-
entiation is limited and yields of otic progenitors are very low
using current protocols [8–10].
Adult stem cells have been overshadowed in recent years
by the advances in reprogramming technology and the devel-
opment of induced pluripotent stem cells (iPSCs). The ability
to reprogram a somatic cell into a pluripotent state was
initially described in 2006 by Takahashi and Yamanaka,
through the exogenous expression of four genes, Oct3/4,
Sox2, c-Myc, and Klf4 [11], spearheading a revolution in
the ﬁeld. Since its inception, this technology has progressed
quickly, leading to increased reprogramming eﬃciency,
applicability to an ever-expanding repertoire of cell types,
and circumvention of genome integration of exogenous
genes (comprehensively reviewed by [12, 13]).
Before iPSCs can be considered viable agents for clinical
application, concerns about the genetic integrity of the
induced cells need addressing. Viral vectors used during
conventional reprogramming can cause insertional muta-
genesis and the activation of oncogenes. In order to avoid
this problem, virus-free and integration-free methods have
been developed, such as the use of episomal plasmids [14,
15] or mRNA-based reprogramming [16]. Messenger RNA
reprogramming would appear to be the safer of the two,
since it has been recently reported that a clinical-grade iPSC
line derived with episomal plasmid vectors presented altered
gene copy numbers, preventing its administration to the
patient [17].
Otic diﬀerentiation from human pluripotent stem cells
has been obtained using embryonic stem cells [3, 6, 18, 19],
and more recently, a few reports have employed iPSCs
[20–25]. However, these early reports on iPSCs have mostly
used integrative retroviral or lentiviral vectors. While it is
expected that the mRNA transfection method of cellular
reprogramming would generate iPSCs with equivalent dif-
ferentiation potential to those generated via viral transduc-
tion, it has not yet been explored if cells reprogrammed
with mRNAs would have a similar ability to diﬀerentiate
into otic lineages.
2. Materials and Methods
2.1. Cell Derivation and Maintenance. The four iPSC lines
used in this study were derived from human foreskin ﬁbro-
blasts (CRL-2429, ATCC) by two diﬀerent methods. FF1
and FF5 lines were transduced with integrating lentiviral vec-
tors encoding SOX2, OCT4, LIN28, and NANOG, while
MIFF1 and MIFF3 lines were reprogrammed using noninte-
grating mRNAs encoding SOX2, OCT4, LIN28, KLF4, and
c-MYC (according to the manufacturer’s instructions, Stem-
gent, USA). All four lines have typical ES cell morphology
and are conﬁrmed to express pluripotency markers such as
SSEA4, Tra1-81, Oct4, and Nanog. All four lines had a nor-
mal 46, XY karyotype. Generation and characterisation of
the lines reprogrammed with nonintegrating mRNAs were
reported in [26], while characterisation of the lentivirus-
reprogrammed lines is presented in the supplementary infor-
mation (Supplementary Fig 1). All iPSC stocks were main-
tained on mouse-inactivated ﬁbroblast feeders in KOSR
medium (as described in [26]) at 37°C and 5% CO2.
2.2. iPSC Diﬀerentiation into Otic Progenitors.Diﬀerentiation
protocols were as reported for hESCs on [6]. In brief,
generation of otic progenitors was achieved by plating
iPSCs in Dulbecco’s Modiﬁed Eagle Medium: Ham’s F12
(DMEM/F12) supplemented with 1x N2 and B27 (abbrevi-
ated as DFNB) (all Life Technologies, UK), FGF3 and
FGF10 (both 50ng/ml) (both R&D Systems, UK) onto
laminin-coated tissue culture plastic. If cells were to be fur-
ther diﬀerentiated along hair cell or auditory neuronal line-
ages, cultures were manually puriﬁed by removing cells
lacking relevant characteristic progenitor morphologies,
enriching speciﬁcally for either otic epithelial progenitor
(OEP) or otic neuronal progenitor (ONP) phenotypes.
Quantiﬁcation of each progenitor colony type was performed
by counting colonies with the characteristic morphologies at
day 4 of diﬀerentiation, before the cleaning of undesired cells
and when the separation between colonies is as its best. At
least 3 randomly selected 20mm2 ﬁelds were sampled from
each T25 ﬂask, and ten ﬂasks were counted per line. Statisti-
cal comparisons were done using 2-way ANOVA. Results
were normalised to 1 cm2 and reported as mean colony
number/cm2 ± SEM.
2.3. iPSC-Derived Progenitor Diﬀerentiation towards Hair
Cell and Sensory Neuronal Fates.Manually enriched popula-
tions of OEPs were dissociated using mild trypsin EDTA
solution (1 : 80) (Sigma-Aldrich, UK) and seeded onto
gelatin-coated tissue culture plastic in DFNB medium sup-
plemented with 1 × 10−6M retinoic acid (Sigma-Aldrich,
UK) and 20ng/ml epidermal growth factor (EGF) (R&D Sys-
tems, UK). Medium was replaced every other day, and cells
were, after 14 days, either ﬁxed in 4% paraformaldehyde or
tested for electrophysiological responses.
ONP cultures were dissociated using trypsin solution
(1 : 10) (Sigma-Aldrich, UK) and seeded onto gelatin-coated
tissue culture plastic in DFNB medium supplemented with
20 ng/ml basic ﬁbroblast growth factor (bFGF) (PeproTech,
UK) and 500ng/ml sonic hedgehog (Shh-C24II) (R&D Sys-
tems, UK). Medium was replaced every other day, with
10 ng/ml neurotrophin-3 (NT3) and 10ng/ml brain-derived
neurotrophic factor (BDNF) (both PeproTech, UK) added
from day 3 onwards and Shh-C24II removed from day 5.
2.4. Electrophysiology Recordings. Whole-cell patch clamp
recordings in voltage clamp mode were made from cultured
cells using an Optopatch ampliﬁer (Cairn Research) at room
temperature. Cells were viewed using an upright microscope
(Leica DMLFS, Germany) and were continuously superfused
with extracellular solution (mM) containing 135 NaCl, 5.8
KCl, 1.3 CaCl2, 0.9 MgCl2, 0.7 NaH2PO4, 5.6 D-glucose, 10
HEPES-free acid, and 2 sodium pyruvate. MEM amino acid
solution (50x, without L-glutamine) and MEM vitamin solu-
tion (100x) were added from concentrates (Fisher Scientiﬁc),
and the pH was adjusted to 7.5. Soda glass patch pipettes
coated with surf wax were ﬁlled with solution (mM) contain-
ing 131 KCl, 3 MgCl2, 1 EGTA–KOH, 5 Na2ATP, 5 HEPES–
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KOH, and 10 Na2 phosphocreatine and adjusted to pH 7.3.
Data were acquired using pClamp software and a Digidata
1440A analogue-to-digital converter (Molecular Devices).
Data were ﬁltered at 2.5 or 5 kHz, sampled at 5 or 50 kHz,
and stored on a computer for oﬄine analysis using Clampﬁt
and Origin (OriginLab) software. Cells were held at -64mV
or -84mV, and positive and negative voltage steps in 10mV
nominal increments were applied. Averages are presented
as mean ± standard error of the mean (SEM).
2.5. Fluorescence Staining. Cells previously ﬁxed for 15min at
room temperature in Phosphate-Buﬀered Saline (PBS) with
4% paraformaldehyde were blocked with 0.1% Triton-X,
5% donkey serum, and 1% bovine serum albumin in PBS.
The following primary antibodies were used in this study:
SOX2 (1 : 100, Millipore), FOXG1, PAX2, HATH1 (ATOH1)
(all 1 : 100, Abcam UK), PAX8 (1 : 100, Santa Cruz), POU4F3
(BRN3C, 1 : 50, Abnova), POU4F1 (BRN3A, 1 : 100, Chemi-
con), and B-tubulin III (1 : 100, Sigma). Secondary antibodies
used were anti-mouse, anti-goat, or anti-rabbit Alexa Fluor
488 and 568 (Molecular Probes, Life Technologies, UK),
while nuclei were counterstained with 4′,6-diamidino-2-
phenylindole (DAPI) (Sigma). Cells were imaged either on
an EVOS FL Cell Imaging System or using the IN Cell Ana-
lyzer 2000 system platforms (GE Healthcare). Quantitative
immunoﬂuorescence was performed on the IN Cell Analyzer
using the Developer Toolbox. Approximately 100-200 ﬁelds
per antibody staining condition and per cell line were ana-
lyzed, capturing between 1,400 and 15,000 cells per condi-
tion, per line. Statistical comparison across the diﬀerent
antibody conditions and reprogramming methods was done
using 2-way ANOVA. Results are reported as mean% ±
SEM. The anti-SSEA3, SSEA4, TRA-1-60, and TRA-1-81
antibodies used for ﬂow cytometry were from BioLegend.
2.6. Quantitative Real-Time PCR (qPCR). Quantitative real-
time PCR was performed on a QuantStudio 12K Flex Real-
Time PCR system (Invitrogen) using TaqMan primers and
universal master mix (Invitrogen). Data was analyzed using
the ΔΔCt method, RPLP0 as a reference gene and normalised
against undiﬀerentiated cells from the same starting popula-
tion. Data is reported either as relative expression (2-ΔΔCt) or
as fold changes against the original population.
3. Results
3.1. iPSCs Can Be Directed towards an Otic Progenitor State.
Otic induction has been demonstrated in hESCs using a two-
step protocol, whereby an intermediate otic progenitor pop-
ulation is generated by exposure to FGF3 and FGF10 during
cell seeding and subsequent monolayer culture, prior to
directing them towards either a hair cell or neuronal fate
(Figure 1(a)) [6]. The state of an otic progenitor is deﬁned
by the expression of key markers associated with the develop-
ing early otic placode (Figures 1(e) and 1(f)). Four iPSC lines,
two generated by lentiviral transduction (FF1 and FF5) and
two by mRNA reprogramming (MIFF1, MIFF3), were cul-
tured for 12 days in FGF3 and FGF10 otic induction medium,
before being probed with antibodies against PAX8, PAX2,
SOX2, and FOXG1. In each case, cells were exposed to
PAX8 antibodies in combination with those raised against
one of the other markers (PAX2, SOX2, or FOXG1) to
identify coexpression in individual cells (e.g., Figures 1(e)
and 1(f)). Highly expressing cells were deﬁned as those
having ﬂuorescence intensities above the 75th percentile
for each antibody independently (as described in [6]). Pop-
ulations of cells that were highly positive for two markers
(coexpression) were then identiﬁed as bona ﬁde otic pro-
genitors. Lentiviral-induced lines produced either 16:6% ±
2:8 SOX2hi/PAX8hi, 21:1% ± 0:23 FOXG1hi/PAX8hi, or
19:9% ± 0:09 PAX2hi/PAX8hi otic cells. On the other hand,
mRNA-reprogrammed lines generated 19:2% ± 2:2 SOX2-
hi/PAX8hi, 17:7% ± 0:2 FOXG1hi/PAX8hi, or 19:3% ± 0:7
PAX2hi/PAX8hi cells. Overall, the yields of otic progenitors
were not diﬀerent between the two types of reprogramming
technique used (n = 2, p > 0:05; Figure 1(f)). Moreover, a
comparable yield of progenitors was observed when the inde-
pendent cell lines were analyzed individually (Supplementary
Figure 2).
The induction of otic marker gene expression was further
validated by qPCR. SOX2, PAX2, PAX8, and FOXG1 tran-
scripts were upregulated in all lines when normalised against
their starting undiﬀerentiated population, displaying similar
patterns of induction between the two reprogramming
methods (Figure 1(g)).
The distinctive morphologies identiﬁed in diﬀerentiating
hESC cultures and described as “otic neural progenitors”
(ONPs) and “otic epithelial progenitors” (OEPs) were also
observed in the iPSC cultures (Figures 1(b) and 1(c)). As
the quantiﬁcation described above did not discriminate
between these two diﬀerent progenitor types, we counted
the diﬀerent colonies obtained based on their morphologies.
The yields of OEPs and ONPs were comparable between
the lentiviral- and the mRNA-reprogrammed lines, with
lentivirus-induced lines generating 25:2 ± 7:5 OEP and
22:2 ± 11:3 ONP colonies/cm2, while the mRNA-
reprogrammed lines produced 15:3 ± 7:8 OEP and 24:4 ±
4:5 ONP colonies/cm2 (n = 2, p > 0:05; Figure 1(d)). The
individual yields of each line are presented in supplemen-
tary ﬁgure 3. Visual identiﬁcation of these morphologically
distinct subpopulations within cultures is important as
manual puriﬁcation of ONPs and OEPs can be used to
select them prior to the second stages of neuronal and hair
cell diﬀerentiation, respectively.
3.2. iPSC-Derived Otic Neuroprogenitors Can Be Induced
towards a Neuronal Fate. Once puriﬁed, ONP cells can be
passaged and maintained in a progenitor state. ONPs gener-
ated using the iPSC lines were subjected to the diﬀerentia-
tion regime deﬁned before using human fetal auditory
stem cells (hFASCs) [5] and later applied to hESC-derived
otic progenitors [6] to obtain sensory neuron-like cells
(Figure 2). When cultured under these conditions, iPSC-
derived ONPs expressed neuronal markers such as β-tubulin
III as well as a transcription factor associated with spiral gan-
glion neuron development, POU4F1 (BRN3A) (Figure 2(c)).
Cells extended neurite projections, making cell networks
(Figure 2(c)). The levels of expression of the neuro-otic
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Figure 1: Continued.
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markers NEUROG and NEUROD were explored with qPCR.
Although the levels of induction—relative to the original
undiﬀerentiated starting population from each line—showed
some variability across the diﬀerent lines (Figure 2(b)), there
were no overall diﬀerences between the reprogramming
methods. Electrophysiological recordings in voltage clamp
mode, from cells generated from an mRNA-reprogrammed
line (MIFF1), showed inward Na+ currents (INa) and small
outward K+ currents (Ik ; 32 pA ± 10 at 0mV; n = 3).
Inward K+ currents (IK1) were also observed in these cells
(Figures 2(d)–2(g)).
3.3. Otic Epithelial Progenitors from iPSCs Can Be Further
Diﬀerentiated towards a Hair Cell-like Phenotype. OEPs gen-
erated through 12 days of FGF3 and FGF10 induction and
manually enriched were cultured in the hair-cell-inducing
medium reported before [5, 6]. Removal of the FGFs and
enhancement with retinoic acid and EGF led to the develop-
ment of cells arranged in small epithelial colonies, displaying
a rearrangement of the actin cytoskeleton, with the formation
of a substantial circumferential ring. This morphology has
been previously associated with hair cell development
in vitro [5]. Relative levels of expression of the hair cell genes
POU4F3 and ATOH1 were comparable across the diﬀerent
lines showing no diﬀerences between reprogramming tech-
niques (Figure 3(b)). Probing these cultures with antibodies
against POU4F3 (BRN3C) and ATOH1 indicated coexpres-
sion in small subsets (Figure 3(c)). Electrophysiological
recordings from cells generated frommRNA reprogramming
(MIFF1) revealed outward K+ currents in 10 out of 12 cells,
which included an inactivating A-type K+ current (n = 7
out of 10) or a delayed rectiﬁer K+ current (n = 3 out of 10).
Inward K+ currents (IK1) were also observed in 4 out of 12
hair cell-like cells, 2 of which also showed an inactivating
A-type K+ current (Figures 3(c)–3(e)). These currents resem-
ble those observed in hair cell-like cells derived from hESCs
[6], with the inward IK1 and outward delayed rectiﬁer K
+ cur-
rent resembling those recorded in prehearing mouse cochlear
hair cells [27]. An inward Na+ current was also observed in
one of these cells.
4. Discussion
An important step towards realising the patient-speciﬁc ther-
apeutic potential of iPSCs is the successful generation of the
clinically relevant lineages. To our knowledge, this is the ﬁrst
report of the production of otic cells from human iPSCs gen-
erated via a mRNA-based nonintegrating method. These
ﬁndings enhance the prospects of developing the use of iPSC
for the treatment of hearing impairment, reducing some of
the safety concerns associated with the generation of repro-
grammed cell lines. Otic progenitor populations, similar to
those obtained from human ESCs, can be generated through
FGF-induction via the FGF3 and FGF10 proteins. These cells
reproducibly coexpress key markers such as PAX8 and
PAX2, SOX2 or FOXG1, with comparable yields between
the reprogramming treatments. As further evidence of
their otic potential, data has been collected to demonstrate
continued diﬀerentiation towards both otic neuronal and
hair cell fates. The expression of neural and hair cell
markers by qPCR did not show a diﬀerent level of induc-
tion between reprogramming methods. Furthermore, cells
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Figure 1: (a) Diagram showing the protocol for the generation of otic progenitors. Colonies of ONPs (b) and OEPs (c), displaying their
typical morphology. Scale bar, 200μm. (d) Bar chart displaying the relative yields of OEPs and ONPs per reprogramming condition (dark
bars are lentivirus-reprogrammed lines, while open bars are for mRNA-reprogrammed ones). (e) Top: ONP colony stained for SOX2 and
PAX8. Bottom: otic epithelial progenitors showing coexpression of FOXG1 and PAX8. Images shown are from the FF1 cell line. Scale bar,
400μm. (f) Bar charts displaying percentages of double-positive otic progenitors, expressing high levels of SOX2/PAX8, FOXG1/PAX8,
and PAX2/PAX8. (g) qPCR of otic progenitors showing relative levels of expression for SOX2, PAX2, PAX8, and FOXG1. Data shown as
fold change against undiﬀerentiated cells from the same starting population.
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Electrophysiological properties of diﬀerentiating neuronal-like cells. Depolarizing and hyperpolarizing voltage steps in 10mV nominal
increments from a holding potential of -84mV revealed Na+ currents (INa; (d), expanded in (e)) in 3 out of 3 neuronal-like cells, small
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Figure 3: (a) Diagram showing the protocol for the generation of hair cell-like cells. (b) qPCR showing relative expression levels of the hair
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Electrophysiological properties of diﬀerentiating hair cell-like cells. To investigate the presence of outward and inward K+ currents, cells
were recorded using the same voltage protocol described in Figure 2. Outward K+ currents were observed in 10 out of 12 hair cell-like
cells; these currents were either an inactivating A-type K+ current (266 ± 62 pA at 0mV, n = 7 out of 10 cells (d)) or a delayed rectiﬁer
current (476 ± 174 pA at 0mV, n = 3 out of 10 cells (f)). Inward K+ currents (IK1: −307 ± 79 pA near -124mV) were observed in 4 out of
12 hair cell-like cells ((e) holding potential -64mV, same as the cell in (d)).
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coexpressing neuronal markers like β-tubulin III alongside
the transcription factor POU4F1 (BRN3A) were detected
in ONP cultures exposed to SHH, NT3, and BDNF, while
cells coexpressing ATOH1 and POU4F3 were observed in
cultures exposed to retinoic acid and EGF. These ﬁndings
suggest that, in principle, mRNA-reprogrammed lines are
equally capable to produce otic lineages than the conven-
tional, lentivirus-induced ones although some caution
must be exercised when extrapolating these results, as only
two lines have been studied in each condition.
Cells derived from the nonintegrative line MIFF1 dis-
played some key physiological responses associated with neu-
rons such as sodium currents, which are required to trigger
action potentials. Hair cell diﬀerentiation produced imma-
ture cell types, similar to those found during development.
Some of the electrophysiological properties detected in the
iPSC-derived cells were similar to the physiological charac-
teristics recorded in vitro from rodent hair cells. For example,
the inward IK1 currents observed in some iPSC-derived hair
cell-like cells are transiently expressed during development
in both outer and inner cochlear hair cells [27]. Outward
delayed rectiﬁer K+ currents, which were also observed in
some hair cell-like cells, are found throughout development
and in mature cochlear hair cells. Nevertheless, the predom-
inant current observed in the hair cell-like cells was the inac-
tivating A-type current, which is found in vestibular hair cells
as well as neurons [28, 29], but not in cochlea hair cells.
Induced PSCs are also proving to be eﬀective tools in
modelling human disease, helping in our understanding of
genetic mutations and drug screening. They have recently
started to be applied to the ﬁeld of otology [24, 25, 30, 31],
as platforms to study the correction of naturally occurring
genetic mutations that induce deafness. We believe that
showing that mRNA, nonintegrative reprogrammed cells
can eﬀectively diﬀerentiate into otic progenitors, should facil-
itate their use in these areas, limiting the genetic variability
introduced by viral, DNA-based reprogramming. Repro-
gramming using mRNAs has an additional advantage over
viral reprogramming, with iPSCs being attainable in as little
as 9 days [32] without then needing to screen for integra-
tions. Although ﬁbroblasts are eﬃciently reprogrammed by
mRNAs, a potential limitation to the widespread application
of this technique is the relative diﬃculty encountered to
deliver mRNAs into blood-derived cell types [33], considered
at this stage the preferred target cell population to generate
iPSCs for therapeutic application. In this regard, the use of
Sendai virus [34]—an RNA virus that can deliver genes with-
out integrating—has gained popularity as it can target blood
lineages. However, Sendai-mediated reprogramming can
leave viral particles contaminating the cells, and being a viral
system, a thorough screening for genetic integration or
potential mutations should be undertaken before the clinical
use of these cells [34]. Since reprogramming by mRNA is a
truly “footprint-free” integration system, future work with
this technology should be aimed at developing more eﬀective
ways to target the blood cell populations. The potential
impact that the tissue of origin could have on the ability of
mRNA-induced iPSCs to generate otic lineages remains
unexplored and will need to be addressed in the future.
5. Conclusions
In this study, we present evidence that iPSC lines that have
been reprogrammed using nonintegrating mRNAs are capa-
ble to diﬀerentiate into otic cell types. The ease of generation
and lack of genetic integration problems make mRNA-
reprogrammed iPSCs highly attractive to the ﬁeld of regener-
ative medicine.
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